Pro: Are ?-blockers beneficial in COPD? - Milan 2023

CDN Connection Issue

It appears that your current network does not allow connection to the CDN (Content Delivery Network) required for this service to function properly.

To resolve this issue, please try the following actions :

• Contact your network administrator : Inform them of this restriction so they can adjust the network settings accordingly.

• Use another network : Try connecting from a different network, such as another Wi-Fi network or a mobile connection.

We apologize for the inconvenience and thank you for your understanding.

International Congresses Milan 2023 Pro: Are ?-blockers beneficial in COPD?

Are ?-blockers beneficial in chronic obstructive pulmonary disease?

Chair(s): Arzu Yorgancioglu, Christopher E. Brightling

Session type: Pro-Con debate

Pro: Are ?-blockers beneficial in COPD?

Alan Kaplan

EVENTS HOME

Replay
Slides

Previous presentation

Next presentation

Session content

Con: Are ?-blockers beneficial in COPD?

Daiana Stolz

Replay

Slides

Pro: Are ?-blockers beneficial in COPD?

Alan Kaplan

Replay

Slides

Discussion and Q&A

Replay

Session aims

to discuss the use of ?-blockers in patients with chronic obstructive pulmonary disease (COPD); to consider the risk-benefit assessment of ?-blocker therapy in COPD; to answer the open question of whether there is a place for use of ?-blockers in our patients.

CDN Connection Issue

The ERS International Congress 2023, Milan

#{title}